Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]
<p>Abstract</p> <p>Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple;...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-05-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/7/1/13 |
| _version_ | 1819055251419824128 |
|---|---|
| author | Weeks Andrew Alfirevic Zarko Vernon Gillian |
| author_facet | Weeks Andrew Alfirevic Zarko Vernon Gillian |
| author_sort | Weeks Andrew |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple; information is provided and signed consent is given. There is a difficulty, however, with obtaining informed consent from women in pregnancy who become eligible only when they develop unforeseen complications, especially when they occur acutely. The problem is compounded with women in labour who may be frightened, vulnerable, in pain, under the effect of opiate analgesia, or all of the above. If research to improve the care of these women is to continue, then special consent procedures are needed. These procedures must ensure that the woman's autonomy is protected whilst recognising that women under these circumstances vary enormously, both in their desire for information and their ability to comprehend it. This paper will discuss the obtaining of consent in this situation, and describe an information and consent pathway for intrapartum research which has been developed in collaboration with consumer groups as a way in which these issues can be tackled.</p> |
| first_indexed | 2024-12-21T13:04:33Z |
| format | Article |
| id | doaj.art-0b9ecd35331c4703855fe5a4b5de9a02 |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-12-21T13:04:33Z |
| publishDate | 2006-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-0b9ecd35331c4703855fe5a4b5de9a022022-12-21T19:03:05ZengBMCTrials1745-62152006-05-01711310.1186/1745-6215-7-13Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]Weeks AndrewAlfirevic ZarkoVernon Gillian<p>Abstract</p> <p>Service users within the NHS are increasingly being asked to participate in clinical research. In Liverpool Women's NHS Foundation Trust, approximately 35% of women take part in research during their pregnancy. For many studies the consent process is simple; information is provided and signed consent is given. There is a difficulty, however, with obtaining informed consent from women in pregnancy who become eligible only when they develop unforeseen complications, especially when they occur acutely. The problem is compounded with women in labour who may be frightened, vulnerable, in pain, under the effect of opiate analgesia, or all of the above. If research to improve the care of these women is to continue, then special consent procedures are needed. These procedures must ensure that the woman's autonomy is protected whilst recognising that women under these circumstances vary enormously, both in their desire for information and their ability to comprehend it. This paper will discuss the obtaining of consent in this situation, and describe an information and consent pathway for intrapartum research which has been developed in collaboration with consumer groups as a way in which these issues can be tackled.</p>http://www.trialsjournal.com/content/7/1/13 |
| spellingShingle | Weeks Andrew Alfirevic Zarko Vernon Gillian Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] Trials |
| title | Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] |
| title_full | Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] |
| title_fullStr | Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] |
| title_full_unstemmed | Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] |
| title_short | Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] |
| title_sort | issues of informed consent for intrapartum trials a suggested consent pathway from the experience of the release trial isrctn13204258 |
| url | http://www.trialsjournal.com/content/7/1/13 |
| work_keys_str_mv | AT weeksandrew issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258 AT alfireviczarko issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258 AT vernongillian issuesofinformedconsentforintrapartumtrialsasuggestedconsentpathwayfromtheexperienceofthereleasetrialisrctn13204258 |